Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GYN
[68Ga]Pentixafor PET/CT imaging in cervical cancer, a comparison with [18F]FDG
Bawinile Hadebe, Thembelihle Nxasana, Lerwine Harry, Maryam Patel, Nontobeko Ndlovu, Mpumelelo Msimang, Mike Sathekge, Siphelele Masikane, Lerato Gabela, Lerwine Harry and Mariza Vorster
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 242218;
Bawinile Hadebe
1University of KwaZulu Natal
Thembelihle Nxasana
1University of KwaZulu Natal
Lerwine Harry
1University of KwaZulu Natal
Maryam Patel
2UKZN
Nontobeko Ndlovu
2UKZN
Mpumelelo Msimang
3NHLS
Mike Sathekge
4Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Private Bag X169, Pretoria, 0001, South Africa
Siphelele Masikane
2UKZN
Lerato Gabela
1University of KwaZulu Natal
Lerwine Harry
5Inkosi Albert Luthuli Hospital
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
[68Ga]Pentixafor PET/CT imaging in cervical cancer, a comparison with [18F]FDG
Bawinile Hadebe, Thembelihle Nxasana, Lerwine Harry, Maryam Patel, Nontobeko Ndlovu, Mpumelelo Msimang, Mike Sathekge, Siphelele Masikane, Lerato Gabela, Lerwine Harry, Mariza Vorster
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242218;
[68Ga]Pentixafor PET/CT imaging in cervical cancer, a comparison with [18F]FDG
Bawinile Hadebe, Thembelihle Nxasana, Lerwine Harry, Maryam Patel, Nontobeko Ndlovu, Mpumelelo Msimang, Mike Sathekge, Siphelele Masikane, Lerato Gabela, Lerwine Harry, Mariza Vorster
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242218;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.